Physicochemical Properties
| Molecular Formula | C4H4N2O |
| Molecular Weight | 96.09 |
| Exact Mass | 96.032 |
| CAS # | 10111-08-7 |
| PubChem CID | 24955 |
| Appearance | Light yellow to yellow solid powder |
| Density | 1.3±0.1 g/cm3 |
| Boiling Point | 296.5±23.0 °C at 760 mmHg |
| Melting Point | 209 °C (dec.)(lit.) |
| Flash Point | 137.5±29.0 °C |
| Vapour Pressure | 0.0±0.6 mmHg at 25°C |
| Index of Refraction | 1.620 |
| LogP | -0.33 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 1 |
| Heavy Atom Count | 7 |
| Complexity | 74.1 |
| Defined Atom Stereocenter Count | 0 |
| InChi Key | XYHKNCXZYYTLRG-UHFFFAOYSA-N |
| InChi Code | InChI=1S/C4H4N2O/c7-3-4-5-1-2-6-4/h1-3H,(H,5,6) |
| Chemical Name | 1H-imidazole-2-carbaldehyde |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: Please store this product in a sealed and protected environment, avoid exposure to moisture. |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| ln Vitro | A new protein tyrosine phosphatase 1B (PTP1B) inhibitor called imidazole-2-carboxaldehyde has significant uses in preventing type 2 diabetes. The amino acids β-alanine and 2-aminobenzoic acid are used to create a condensation process that yields ligands with tridentate Schiff base carboxylates. Additionally, it has been engaged in the allylation of aldimines guided by imidazoles. |
Solubility Data
| Solubility (In Vitro) | DMSO: 25 mg/mL (260.17 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.5 mg/mL (26.02 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.5 mg/mL (26.02 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 10.4069 mL | 52.0346 mL | 104.0691 mL | |
| 5 mM | 2.0814 mL | 10.4069 mL | 20.8138 mL | |
| 10 mM | 1.0407 mL | 5.2035 mL | 10.4069 mL |